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ndothelial cells express two classic cadherins, VE-
cadherin and N-cadherin. The importance of VE-
cadherin in vascular development is well known;
however, the function of N-cadherin in endothelial cells re-
mains poorly understood. Contrary to previous studies, we
found that N-cadherin localizes to endothelial cell–cell
junctions in addition to its well-known diffusive membrane
expression. To investigate the role of N-cadherin in vascu-
lar development, N-cadherin was speciﬁcally deleted from
endothelial cells in mice. Loss of N-cadherin in endothelial
cells results in embryonic lethality at mid-gestation due to
E
 
severe vascular defects. Intriguingly, loss of N-cadherin
caused a signiﬁcant decrease in VE-cadherin and its cyto-
plasmic binding partner, p120ctn. The down-regulation of
both VE-cadherin and p120ctn was conﬁrmed in cultured
endothelial cells using small interfering RNA to knock-
down N-cadherin. We also show that N-cadherin is im-
portant for endothelial cell proliferation and motility. These
ﬁndings provide a novel paradigm by which N-cadherin
regulates angiogenesis, in part, by controlling VE-cadherin
expression at the cell membrane.
 
Introduction
 
Vascular remodeling is the end result of a complex series of
dynamic cell–cell and cell–ECM interactions driven by fluid
shear stress and angiogenic growth factors (Carmeliet, 2000;
Yancopoulos et al., 2000; Jain, 2003). The adherens junction
provides strong cell–cell adhesion mediated by the cadherin–
catenin complex via its linkage to the actin cytoskeleton
(Wheelock and Johnson, 2003). Most cells express multiple
cadherin subtypes; however, the interrelationship and func-
tional contribution of the individual cadherins in cell adhesion
and signaling is poorly understood. N-cadherin is normally
concentrated at cell–cell contact sites in most cell types where
it is expressed. However, in endothelial cells (ECs) N-cadherin
displays an unusual nonjunctional distribution (Navarro et al.,
1998) thought to be important for EC–mural cell (i.e., pericyte
and smooth muscle) interactions (Gerhardt and Betsholtz,
2003; Dejana, 2004). Injection of N-cadherin function-block-
ing antibodies into the developing chick brain disrupted EC–
pericyte interactions, leading to vascular abnormalities and
hemorrhaging (Gerhardt et al., 2000). Recent evidence indi-
cates that the bioactive lipid, sphingosine1-phosphate, plays an
important role in stabilizing N-cadherin–mediated EC–mural
cell interactions both in vitro and in vivo (Paik et al., 2004).
Hence, the prevailing view is that N-cadherin’s primary func-
tion in ECs is to promote heterotypic cell interactions with
mural cells.
In this study, we genetically manipulate N-cadherin ex-
pression in vivo and in vitro to examine its function in ECs.
Endothelial-specific deletion of N-cadherin from the develop-
ing vascular system led to an unexpected phenotype reminis-
cent of the VE-cadherin knockout mouse phenotype (Carmeliet
et al., 1999; Gory-Faure et al., 1999). Indeed, VE-cadherin was
significantly down-regulated in the mutant embryos, demonstrat-
ing that N-cadherin is genetically upstream of VE-cadherin.
 
Results and discussion
 
Endothelial-restricted deletion of 
N-cadherin leads to vascular defects
 
We report here that N-cadherin is also found at intercellular
junctions colocalized with VE-cadherin in human umbilical
vein endothelial cells (HUVEC) and human dermal microvas-
cular endothelial cells (HMVEC), suggesting an unappreciated
role for N-cadherin in EC–EC interactions (Fig. 1). To deter-
mine N-cadherin’s function in ECs during vascular develop-
ment, N-cadherin floxed mice (Kostetskii et al., 2005) were
bred to Tie2-Cre transgenic mice (Kisanuki et al., 2001) to de-
lete N-cadherin specifically from the EC lineage. Unexpectedly,
N-cadherin loss in ECs caused recessive embryonic lethality at
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mid-gestation, before mural cell investment, raising the possi-
bility of an important role for N-cadherin in EC–EC interac-
tions. Mutant embryos were developmentally delayed com-
pared with their wild-type littermates at E9.5, with lack of
blood circulation accompanied by pericardial effusion (Fig. 2,
A and B). By E10.5, mutant embryos were deteriorated (Fig. S1,
available at http://www.jcb.org/cgi/content/full/jcb.200411127/
DC1). Mutant embryos exhibited defective embryonic and yolk
sac vasculature, including the lack of large vessels in the yolk
sac. In contrast, wild-type yolk sac displayed great vessels at
this stage (Fig. 2, C and D). Embryos also were examined by
whole-mount staining with platelet endothelial cell adhesion
molecule (PECAM) antibody to show the emerging vasculature.
Mutant embryos exhibited an abnormal vascular plexus with
smaller, less developed vessels in the brain and intersomitic re-
gion (Fig. 2 C; Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200411127/DC1). Sectioning of the PECAM-
stained mutant embryo showed smaller dorsal aorta and multiple
endothelial vesicles instead of one large cardinal vein compared
with the wild-type embryo (Fig. 2, D and E). Interestingly,
endocardial cells in the heart tube appeared enlarged or swollen
in the mutant embryo compared with the elongated morphology
Figure 1. Cellular localization of cadherins in endothelial
cells. Double immunostaining of N-cadherin and VE-cadherin
in HUVEC (A–C) and HMVEC (D–F). N-cadherin exhibits both
diffuse, nonjunctional as well as junctional staining (A and D).
In contrast, VE-cadherin is restricted to regions of cell–cell
contact (B and E) where it colocalizes with N-cadherin (C
and F). The nuclei staining is due to nonspecific background.
Bars, 50  m.
Figure 2. Loss of N-cadherin in endothelial cells
leads to embryonic lethality. Whole-mount images
of E9.5 embryos without (A) and with (B) yolk sac.
Mutants (cko) lack well-defined blood vessels in
yolk sac compared with large vessels (arrow) ob-
served in wild-type (wt) embryos (B). Whole-mount
PECAM stain of E9.0 embryos (C). Sections of PE-
CAM-stained embryos (D and E) show dorsal
aorta (arrow) and cardinal vein (arrowheads) in
wild-type (D) and cko (E) embryos. Note the
smaller dorsal aorta (arrow) in the cko (E) com-
pare with wild-type (D) embryo. Instead of one
large cardinal vein (arrowhead) in wild-type (D),
three smaller vessels (arrowheads) are seen in the
mutant (E). The endocardium (arrows) appears
swollen in the mutant (G) compared with wild-type
(F). Transmission EM of dorsal aorta (H–K) and
endocardium (L and M) show the morphology of
the wild-type (wt) and mutant (cko) cells. Higher
magnification of boxed areas (I) illustrates the cell
death process in the mutant endothelial cells (J
and K). Endocardial cells have lost cell–cell con-
tact in the mutant (M) compared with wild-type (L).
Bars: D–G, 100  m; H, I, L, and M, 2  m; J and
K, 500 nm. 
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of the wild-type cells (Fig. 2, F and G). Although the Tie2-
Cre transgene is not active in the myocardium, the myocardial
layer appeared less compact in the mutant embryo compared
with the wild-type embryo, suggesting cross-talk between the
endocardium and myocardium involving cadherin (Fig. 2, F
and G).
To examine ECs at the ultrastructural level, transmission
EM was performed on the E9.5 embryos. Somewhat unexpect-
edly, EC–EC contacts in the dorsal aorta appeared relatively
normal in the mutant embryo (Fig. 2, H and I), although the lu-
men was smaller than that in the wild-type embryo where it
was too large for the field of view (Fig. 2 H). Many endothelial
cells in the N-cadherin CKO embryo, compared with the wild-
type embryo, showed morphological signs of cell death includ-
ing blebbing representative of programmed cell death and vac-
uoles representative of autophagic cell death (Fig. 2, J and K).
In contrast to the dorsal aorta, endocardial cells in the mutant
embryo appeared rounded and less cohesive compared with
those in the wild-type embryo (Fig. 2, L and M).
 
VE-cadherin is dependent on N-cadherin
 
To confirm the efficiency of the Tie2-Cre–mediated deletion,
we examined N-cadherin expression in the endocardium by im-
munofluorescence. Compared with myocardium, N-cadherin is
weakly expressed in endocardium of the wild-type embryo (Fig.
3 A, inset); however, it is both present at cell–cell contacts and
found diffusely distributed on the cell surface, similar to HU-
VEC (Fig. 1). In contrast, N-cadherin was absent from the en-
docardium in the mutant embryo (Fig. 3 B), but present in the
myocardium. Although direct comparison of tissue-specific and
constitutive knockout phenotypes can be difficult due to the
timing of the deletion, the similarity between the N-cadherin
CKO and VE-cadherin KO phenotypes (Carmeliet et al., 1999;
Gory-Faure et al., 1999) led us to examine VE-cadherin expres-
sion in our CKO embryos using immunofluorescence micros-
copy. Surprisingly, the VE-cadherin signal was significantly de-
creased in the endocardium and dorsal aorta (Fig. S3, available
at http://www.jcb.org/cgi/content/full/jcb.200411127/DC1) of
the N-cadherin CKO embryo compared with the strong immu-
nostaining seen in the wild-type (Fig. 3, C and D). The endothe-
lial identity of the CKO tissue was confirmed by positive stain-
ing of an adjacent section with PECAM antibody (Fig. 3 E).
Furthermore, Western blot analysis of yolk sac lysates derived
from CKO embryos showed a dramatic reduction of VE-cad-
herin compared with wild-type (Fig. 3 H). Thus, our results pro-
vide the first evidence that N-cadherin can regulate the cellular
level of VE-cadherin.
The catenin family consists of several members, including
 
 
 
-, 
 
 
 
-, and 
 
 
 
-catenin, and p120ctn, which bind the highly con-
served cytoplasmic domain and regulate cadherin adhesive ac-
tivity (Lilien et al., 2002). Recent data indicate that the jux-
tamembrane-binding catenin, p120ctn, plays a critical role in
controlling cadherin turnover by regulating the entry of cad-
herins into a degradative endocytic pathway (Davis et al., 2003;
Xiao et al., 2003; Kowalczyk and Reynolds, 2004). Previous
work from our laboratory revealed that the level or cellular
distribution of p120ctn is regulated by N-cadherin in cultured
embryonic myocytes (Luo and Radice, 2003) and neural crest
cells (Xu et al., 2001). Interestingly, p120ctn also showed a sig-
nificant decrease in endocardium in N-cadherin CKO embryo
compared with wild-type embryo (Fig. 3, F and G). These in
vivo data indicate N-cadherin is critical for the normal regulation
of VE-cadherin expression, possibly through controlling p120ctn
levels. This may explain the similar vascular phenotypes seen in
EC-specific N-cadherin CKO and VE-cadherin KO mice.
 
N-cadherin regulates VE-cadherin 
expression in human endothelial cells
 
To further examine the function of N-cadherin in endothelial
cells, a small interfering RNA (siRNA) approach was used to
knockdown N-cadherin in HUVEC. Consistent with our in
vivo findings, knockdown of N-cadherin resulted in loss of
VE-cadherin from endothelial cell–cell junctions (Fig. 4 E).
Furthermore, both junctional and nonjunctional p120ctn im-
munostaining was significantly reduced after knockdown of
N-cadherin in HUVEC (Fig. 4 F). Western blot analysis con-
firmed the reduction of both VE-cadherin (60%) and p120ctn
(65%) in cultured cells (Fig. 4 M). Beta-catenin levels also
were reduced (unpublished data). In contrast, siRNA knock-
down of VE-cadherin did not affect N-cadherin distribution or
expression level (Fig. 4 K). In addition, p120ctn remained lo-
calized at cell–cell contacts after VE-cadherin depletion (Fig.
4 L). Western blot analysis confirmed that VE-cadherin did not
affect N-cadherin expression level; however, a modest reduc-
tion (35%) of p120ctn was observed consistent with decreased
VE-cadherin levels (Fig. 4 N). Thus, the ability of N-cadherin
to regulate VE-cadherin and p120ctn expression was observed
in both mouse and human endothelial cells, and this is a nonre-
ciprocal relationship because VE-cadherin knockdown had no
effect on N-cadherin expression.
Figure 3. Cadherin/catenin expression in endothelial-restricted N-cadherin
CKO embryos. Immunofluorescence was performed on E9.5 embryos for
N-cadherin (A and B), VE-cadherin (C and D), PECAM (E), and p120ctn
(F and G). In addition to its diffuse cell surface localization, N-cadherin is
also observed at cell–cell contacts (arrows) between endocardial cells
(A, inset). Western analysis of VE-cadherin in yolk sacs from wild-type (wt)
and mutant (cko) embryos (H). m, myocardium; e, endocardium. Bars, 50  m. 
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To determine whether VE-cadherin expression was af-
fected at the mRNA level, real-time PCR analysis was per-
formed on HUVEC. VE-cadherin mRNA levels were not
changed after knockdown of N-cadherin (Fig. S3), indicating
posttranscriptional regulation is responsible for the down-regu-
lation of VE-cadherin.
 
N-cadherin is important for endothelial 
cell proliferation and motility
 
We observed fewer cell numbers 24 h after knockdown of
N-cadherin compared with control, or VE-cadherin knockdown.
No significant increase in apoptosis was observed after trans-
fection of the N-cadherin siRNA (unpublished data). There-
fore, we examined cellular proliferation in HUVEC cultures.
We found that knockdown of N-cadherin caused a significant
growth arrest by BrdU incorporation and Ki67 labeling (50%
reduction in proliferation rate compared with control; Fig. 5
A). The growth inhibitory effect was attributed to loss of N-cad-
herin, rather than a decrease in VE-cadherin, because VE-cad-
herin knockdown alone had no effect on cellular proliferation.
Hence, a decrease in EC proliferation may be responsible, at
least in part, for the lack of vascular development in the N-cad-
herin CKO embryos.
In addition to EC proliferation, vascular remodeling re-
quires migration and assembly of ECs into tubular structures.
We previously showed that loss of N-cadherin in neural crest
cells led to faster migration accompanied by a loss of direction-
ality (Xu et al., 2001). Therefore, we asked whether loss of
N-cadherin would influence EC motility using a transwell mi-
gration assay. We found that knockdown of N-cadherin re-
sulted in enhanced EC migration (50%) compared with control
(Fig. 5 B), consistent with our study on neural crest cells (Xu
et al., 2001). The increased motility was attributed to loss of
N-cadherin rather than a decrease in VE-cadherin, because VE-
cadherin knockdown alone had no effect on cell motility.
Modulation of integrin adhesive activity is important for
vascular morphogenesis (Byzova et al., 2000). Recent evi-
dence has shown that class 3 semaphorins (Sema3a) nega-
tively regulate 
 
 
 
1-integrin function and that loss of Sema3a
leads to activation of 
 
 
 
1-integrin and is associated with stimu-
lation of endothelial cell migration and severe angiogenic de-
fects (Serini et al., 2003). Interestingly, 
 
 
 
1-integrin was up-
regulated (threefold) after knockdown of N-cadherin (Fig. 5
C), providing a possible explanation for the increased migra-
tion rate observed in the transwell assay. In contrast, siRNA
knockdown of VE-cadherin did not affect migration or 
 
 
 
1-
integrin expression. In support of cross-talk between N-cad-
herin and 
 
 
 
1-integrin in vivo, we observed a similar increase
in 
 
 
 
1-integrin after deleting N-cadherin in adult myocardium
using an inducible cardiac-specific Cre gene (Kostetskii et al.,
2005). Thus, the up-regulation of 
 
 
 
1-integrin after loss of
N-cadherin may interrupt finely controlled EC migration, as
well as directionality, contributing to the vascular defects ob-
served in N-cadherin CKO embryos.
 
Conclusions
 
It was previously thought that N-cadherin’s primary function
in ECs was to facilitate EC–mural cell interactions (Dejana,
2004); however, our in vivo and in vitro studies indicate that
N-cadherin plays a fundamental role in angiogenesis by modu-
lating adherens junction components and EC behavior. The vas-
cular phenotype observed in N-cadherin CKO embryos is simi-
lar to that of VE-cadherin–null mice (Carmeliet et al., 1999;
Gory-Faure et al., 1999), consistent with N-cadherin acting up-
stream of VE-cadherin. However, the vascular phenotype is
unlikely explained by reduction of VE-cadherin alone because
Figure 4. N-cadherin regulates VE-cadherin levels in human
endothelial cells. Immunofluorescence of endothelial cells after
cadherin knockdown. HUVEC were transfected with control
siRNA (A–C and G–I), N-cadherin siRNA (D–F), or VE-cadherin
siRNA (J–L). After 48 h, the cells were double stained for N-cad-
herin (A, D, H, and K) and VE-cadherin (B, E, G, and J), or
p120ctn (C, F, I, and L). Note loss of VE-cadherin (E) and
p120ctn (F) after knockdown of N-cadherin. In contrast, knock-
down of VE-cadherin did not significantly affect N-cadherin (K)
or p120ctn (L). Western analysis of HUVEC after transfection
with control (con), N-cadherin (N), or VE-cadherin (VE) siRNA
(M and N). Quantification of the knockdown from three indepen-
dent experiments. Bars, 50  m. 
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comparison of N-cadherin and VE-cadherin function in HUVEC
suggests unique functions for N-cadherin in cellular prolifera-
tion and motility.
The myocardial defect observed in the EC-specific N-cad-
herin CKO embryo was unexpected. Interestingly, a similar
myocardial defect was also observed in VE-cadherin–null em-
bryos (Carmeliet et al., 1999), which could only result from
VE-cadherin loss in the endocardium because it is not ex-
pressed in the myocardium. We previously demonstrated that
myocardial-specific expression of cadherin was sufficient to
postpone embryonic lethality of the N-cadherin–null embryo in
the absence of EC expression (Luo et al., 2001). However, the
vascular phenotype could not be examined definitively in these
partially rescued embryos because of N-cadherin’s requirement
in other noncardiac cell lineages. We conclude that both the
EC-specific N-cadherin CKO and VE-cadherin KO phenotypes
are more complicated than simply perturbing EC function, and
likely involve cross-talk between the endocardium and myo-
cardium via cadherin-mediated signaling.
To our knowledge, this is the first report of one classical
cadherin controlling the fate of another classical cadherin. This
regulatory scenario may be specific to ECs that undergo dy-
namic cell–cell rearrangement during vascular morphogenesis.
In addition, regulation of EC–EC interactions by N-cadherin
may be important for controlling vascular permeability. Both
the unique nonjunctional distribution of N-cadherin and its
dominant role in EC behavior suggest a novel mechanism for
cadherin cross-talk in these cells. The reduction in p120ctn af-
ter N-cadherin depletion suggests this juxtamembrane-binding
catenin may play a role in this process. In summary, our studies
demonstrate that N-cadherin function is required for angiogen-
esis, and redefine the hierarchical relationship of the structural
components of the interendothelial cell junction.
 
Materials and methods
 
Analysis of mutant embryos
 
To generate EC-specific deletion of N-cadherin, N-cad
 
null/
 
 
 
, Tie2-Cre mice
were mated with N-cad
 
flox/flox
 
 mice and embryos were recovered from
timed pregnancies. Animal studies were approved by the University of
Pennsylvania IACUC committee. All experiments were performed in accor-
dance with National Institutes of Health guidelines and regulations.
Whole-mount PECAM staining on E9.0 embryos was performed as
previously described (Cattelino et al., 2003). Transmission EM was per-
formed on a transverse section through the thoracic region of E9.5 em-
bryos according to standard protocol. Immunofluorescence of cryosections
stained with antibodies for N-cadherin (Zymed Laboratories), VE-cadherin
(BD Biosciences), p120ctn (BD Biosciences), or PECAM (BD Biosciences)
were visualized with a confocal microscope.
 
RNA interference experiments
 
HUVEC (Cambrex), 6th generation or less, were cultured in EGM BulletKit
medium (CC-3124; Cambrex) and HMVEC (Cambrex), 2nd generation,
were cultured in EGM MV BulletKit medium (CC-3125; Cambrex) accord-
ing to the manufacturer’s recommendation. For RNA interference analysis,
CDH2 (human N-cadherin) and CDH5 (human VE-cadherin) SMARTpools
(Dharmacon) were delivered into 70% confluent cells with Targefect-
siRNA kit (Targeting Systems) at the final concentration of 100 nM accord-
ing to the manufacturer’s protocol. In addition, VE-cadherin expression
was reduced after transfection with individual N-cadherin siRNA derived
from the SMARTpool. Nontargeting siRNA pool (Dharmacon) at the same
concentration was used as a control for above RNA interference assays.
After 48 h transfection, cell lysates were collected with RIPA buffer for
Western blot analysis or cells were fixed with 2% PFA followed by 0.3%
Triton X-100 for immunofluoresence. In addition to the above antibodies,
 
 
 
1-integrin (BD Biosciences) and VE-cadherin (Sigma-Aldrich) were used
for the Western blots. For normalization of signals, blotting was also per-
formed with 
 
 
 
-actin antibody (Sigma-Aldrich), followed by alkaline phos-
phatase–conjugated secondary antibody and chemifluorescent processing
(ECF; Amersham Biosciences). Densitometry of samples was performed
via use of ImageQuant (Molecular Dynamics) software.
 
Cell proliferation and migration assays
 
BrdU (Sigma-Aldrich) incorporation and Ki-67 (DakoCytomation) labeling
were used to monitor cell proliferation after 24 h transfection. For invasion
assays, cells were transfected with N-cadherin SMARTpool for 24 h, and
2.5 
 
 
 
 10
 
5
 
 cells were loaded into the top of a 24-well Matrigel invasion
chamber assay plate (BioCoat; BD Biosciences). After 36 h in Matrigel,
fluorometric detection was performed using a CytoFluor multi-well plate
reader according to the manufacturer’s protocol (BD ViaSante).
 
Statistics
 
Data are expressed as mean 
 
 
 
 SEM. Comparisons between groups were
performed with a two-tailed 
 
t
 
 test using Microsoft Excel software. P 
 
 
 
 0.05
was considered statistically significant.
 
Online supplemental material
 
Fig. S1: whole-mount images of E10.5 embryos. Fig. S2: higher magnifi-
cation of whole-mount PECAM-stained E9.0 embryos. Fig. S3: VE-cad-
herin and PECAM expression in dorsal aorta of E9.5 embryos; real-time
PCR analysis of VE-cadherin mRNA expression after knockdown of N-cad-
herin in HUVEC. Online supplemental material available at http://
www.jcb.org/cgi/content/full/jcb.200411127/DC1.
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